Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2015 08:00 ET | Source: Bioblast Pharma Ltd.

BioBlast Pharma Announces Positive Preclinical Proof-of-Concept Results of Its Novel Mitochondrial Protein Replacement Platform in Friedreich's Ataxia

TEL AVIV, Israel, March 26, 2015 (GLOBE NEWSWIRE) -- BioBlast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company announced today positive preclinical in vitro...
March 26, 2015 08:00 ET | Source: Spine Injury Solutions, Inc.

Spine Pain Management Schedules Interactive Conference Call to Present Full Year 2014 Financial Results and Provide Business Development Update

HOUSTON, March 26, 2015 (GLOBE NEWSWIRE) -- Spine Pain Management, Inc. (OTCQB:SPIN), a technology-driven, medical service, device and healthcare solution company servicing the multi-billion dollar...
March 26, 2015 08:00 ET | Source: Novavax, Inc.

Novavax Prices Public Offering of Common Stock

GAITHERSBURG, Md., March 26, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
March 26, 2015 08:00 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics Enters Agreement to Sell Former Facilities for $23 Million

MIAMI LAKES, Fla., March 26, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) announced that its wholly-owned subsidiary – Diamedix Corporation – has entered into a purchase...
March 26, 2015 07:30 ET | Source: BG Medicine, Inc.

BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology

WALTHAM, Mass., March 26, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today the publication of a landmark study, in the Journal of the American College of Cardiology, reporting...
March 26, 2015 07:30 ET | Source: Otonomy, Inc.

Otonomy Initiates Phase 2 Clinical Trial for AuriPro(TM) in Label Expansion Indication

SAN DIEGO, March 26, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
March 26, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Expands Patient Population in NeuVax(TM) (nelipepimut-S) and trastuzumab Phase 2b Combination Clinical Trial in HER2 1+/2+ Patients

PORTLAND, Ore., March 26, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that...
March 26, 2015 07:01 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Announces Successful Top-Line Results From NAFLD/NASH Clinical Trial of Emricasan

- Conclusions Support Registration Strategy Including NASH Cirrhosis - - Detailed Data to be Presented in Late-Breaker Poster at EASL Meeting - SAN DIEGO, March 26, 2015 (GLOBE NEWSWIRE) --...
March 26, 2015 06:30 ET | Source: AngioDynamics

AngioDynamics to Report Fiscal 2015 Third Quarter Financial Results

ALBANY, N.Y., March 26, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
March 25, 2015 19:37 ET | Source: REVA Medical Inc

REVA Appoints Scott Huennekens to Board of Directors

SAN DIEGO, March 25, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") today announced that Scott Huennekens, a recognized business executive in the medical device...